drug protocol number

RPC01-3203

drug sponsor

Celgene

drug study

Ozanimod HCl

drug trial site

King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase